Jill M Ferdinands1, Lauren E W Olsho2, Anna A Agan3, Niranjan Bhat4, Ryan M Sullivan3, Mark Hall5, Peter M Mourani6, Mark Thompson7, Adrienne G Randolph3. 1. Influenza Division, US Centers for Disease Control and Prevention Battelle Memorial Institute, Atlanta, Georgia. 2. Abt Associates, Inc., Cambridge. 3. Department of Anesthesia, Perioperative and Pain Medicine (Critical Care), Boston Children's Hospital, Massachusetts. 4. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, Ohio. 6. Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora. 7. Influenza Division, US Centers for Disease Control and Prevention.
Abstract
BACKGROUND: No studies have examined the effectiveness of influenza vaccine against intensive care unit (ICU) admission associated with influenza virus infection among children. METHODS: In 2010-2011 and 2011-2012, children aged 6 months to 17 years admitted to 21 US pediatric intensive care units (PICUs) with acute severe respiratory illness and testing positive for influenza were enrolled as cases; children who tested negative were PICU controls. Community controls were children without an influenza-related hospitalization, matched to cases by comorbidities and geographic region. Vaccine effectiveness was estimated with logistic regression models. RESULTS: We analyzed data from 44 cases, 172 PICU controls, and 93 community controls. Eighteen percent of cases, 31% of PICU controls, and 51% of community controls were fully vaccinated. Compared to unvaccinated children, children who were fully vaccinated were 74% (95% CI, 19% to 91%) or 82% (95% CI, 23% to 96%) less likely to be admitted to a PICU for influenza compared to PICU controls or community controls, respectively. Receipt of 1 dose of vaccine among children for whom 2 doses were recommended was not protective. CONCLUSIONS: During the 2010-2011 and 2011-2012 US influenza seasons, influenza vaccination was associated with a three-quarters reduction in the risk of life-threatening influenza illness in children. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: No studies have examined the effectiveness of influenza vaccine against intensive care unit (ICU) admission associated with influenza virus infection among children. METHODS: In 2010-2011 and 2011-2012, children aged 6 months to 17 years admitted to 21 US pediatric intensive care units (PICUs) with acute severe respiratory illness and testing positive for influenza were enrolled as cases; children who tested negative were PICU controls. Community controls were children without an influenza-related hospitalization, matched to cases by comorbidities and geographic region. Vaccine effectiveness was estimated with logistic regression models. RESULTS: We analyzed data from 44 cases, 172 PICU controls, and 93 community controls. Eighteen percent of cases, 31% of PICU controls, and 51% of community controls were fully vaccinated. Compared to unvaccinated children, children who were fully vaccinated were 74% (95% CI, 19% to 91%) or 82% (95% CI, 23% to 96%) less likely to be admitted to a PICU for influenza compared to PICU controls or community controls, respectively. Receipt of 1 dose of vaccine among children for whom 2 doses were recommended was not protective. CONCLUSIONS: During the 2010-2011 and 2011-2012 US influenza seasons, influenza vaccination was associated with a three-quarters reduction in the risk of life-threatening influenza illness in children. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Jessie R Chung; Brendan Flannery; Manjusha Gaglani; Michael E Smith; Evelyn C Reis; Robert W Hickey; Michael L Jackson; Lisa A Jackson; Edward A Belongia; Huong Q McLean; Emily T Martin; Hannah E Segaloff; Sara S Kim; Manish M Patel Journal: JAMA Pediatr Date: 2020-07-01 Impact factor: 16.193
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Ekaterina Nekrasova; Melissa S Stockwell; Russell Localio; Justine Shults; Chelsea Wynn; Laura P Shone; Lindsay Berrigan; Chelsea Kolff; Miranda Griffith; Andrew Johnson; Alessandra Torres; Douglas J Opel; Alexander G Fiks Journal: Hum Vaccin Immunother Date: 2020-02-04 Impact factor: 3.452
Authors: Wändi Bruine de Bruin; Annika Wallin; Andrew M Parker; JoNell Strough; Janel Hanmer Journal: Med Decis Making Date: 2017-05-05 Impact factor: 2.583
Authors: Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Wesley H Self; Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Jonathan McCullers; Sandra R Arnold; Richard G Wunderink; Evan J Anderson; Stephen Lindstrom; Alicia M Fry; Ivo M Foppa; Lyn Finelli; Anna M Bramley; Seema Jain; Marie R Griffin; Kathryn M Edwards Journal: JAMA Date: 2015-10-13 Impact factor: 56.272
Authors: Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry Journal: Pediatr Infect Dis J Date: 2016-03 Impact factor: 2.129